Ibex’s Daphna Laifenfeld On AI-Powered Cancer Diagnostics, Company Raising $38 Million In Series B Funding And The Future Of Personalized Medicine Founded in 2016, Ibex Medical Analytics pioneered cancer diagnostics in pathology and is the first and so far the only company to deploy live AI solutions in laboratories and hospitals across the world.